Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001628280-24-046708
Filing Date
2024-11-08
Accepted
2024-11-08 16:47:21
Documents
3
Period of Report
2024-11-07

Document Format Files

Seq Description Document Type Size
1 FORM 3 wk-form3_1731102434.html 3  
1 FORM 3 wk-form3_1731102434.xml 3 3536
2 EX-24 lopezcarlospowerofattorn.htm EX-24 644
3 lopezcarlospowerofattorn001.jpg GRAPHIC 265492
  Complete submission text file 0001628280-24-046708.txt   371502
Mailing Address 10900 WILSHIRE BLVD SUITE 600 LOS ANGELES CA 90024
Business Address 10900 WILSHIRE BLVD SUITE 600 LOS ANGELES CA 90024 310-388-6706
ChromaDex Corp. (Issuer) CIK: 0001386570 (see all company filings)

EIN.: 262940963 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2833 Medicinal Chemicals & Botanical Products
(CF Office: 03 Life Sciences)

Mailing Address 10900 WILSHIRE BLVD., SUITE 600 LOS ANGELES CA 90024
Business Address
Lopez Carlos Luis (Reporting) CIK: 0002042509 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37752 | Film No.: 241441420